Payment overview · 2025
General Payments
$189.09
1 reported records · 1 companies
Healthcare provider profile · identity verified
Vickie T. Pham, FNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · LAKE OSWEGO, OR · NPI 1821598921
Verified facts
What the public records show
CMS Open Payments records show Vickie T. Pham, FNP received $189.09 in general payments during 2025 across 1 reported records.
Edwards Lifesciences Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $189.09 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $189.09 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SAPIEN 3 Ultra RESILIA Normalized: sapien 3 ultra resilia |
Device | Edwards Lifesciences Corporation | $189.09 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Oxycodone Hcl | Oxycodone Hcl | 183 | 31 |
| Gabapentin | Gabapentin | 170 | 21 |
| Eliquis | Apixaban | 132 | 15 |
| Baclofen | Baclofen | 120 | 20 |
| Furosemide | Furosemide | 120 | 14 |
| Losartan Potassium | Losartan Potassium | 116 | 22 |
| Lorazepam | Lorazepam | 110 | 13 |
| Amlodipine Besylate | Amlodipine Besylate | 108 | 22 |
| Atorvastatin Calcium | Atorvastatin Calcium | 108 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 105 | 21 |
| Lisinopril | Lisinopril | 90 | 14 |
| Levothyroxine Sodium | Levothyroxine Sodium | 89 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 88 | 16 |
| Tramadol Hcl | Tramadol Hcl | 76 | 17 |
| Metoprolol Succinate | Metoprolol Succinate | 72 | 15 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 70 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 67 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 63 | 16 |
| Ozempic | Semaglutide | 61 | 14 |
| Sertraline Hcl | Sertraline Hcl | 60 | 11 |
| Jardiance | Empagliflozin | 58 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 57 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 57 | 21 |
| Levetiracetam | Levetiracetam | 48 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 48 | suppressed |
| Latanoprost | Latanoprost | 46 | suppressed |
| Pregabalin | Pregabalin | 45 | suppressed |
| Cephalexin | Cephalexin | 39 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 39 | suppressed |
| Potassium Chloride | Potassium Chloride | 38 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 36 | suppressed |
| Clonazepam | Clonazepam | 34 | suppressed |
| Ketoconazole | Ketoconazole | 34 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 34 | suppressed |
| Mirtazapine | Mirtazapine | 34 | suppressed |
| Prednisone | Prednisone | 33 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 31 | 31 |
| Humulin N | Insulin Nph Human Isophane | 31 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 31 | suppressed |
| Lacosamide | Lacosamide | 31 | suppressed |
| Chlorthalidone | Chlorthalidone | 29 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Metformin Hcl | Metformin Hcl | 27 | suppressed |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Clobazam | Clobazam | 26 | suppressed |
| Movantik | Naloxegol Oxalate | 26 | suppressed |
| Spironolactone | Spironolactone | 26 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone Dipropionate | 25 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 25 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 25 | suppressed |
| Memantine Hcl | Memantine Hcl | 25 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 24 | suppressed |
| Sucralfate | Sucralfate | 24 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Lactulose | Lactulose | 23 | suppressed |
| Allopurinol | Allopurinol | 22 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 22 | 15 |
| Xarelto | Rivaroxaban | 22 | suppressed |
| Carbamazepine Er | Carbamazepine | 21 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 21 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 21 | suppressed |
| Omeprazole | Omeprazole | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Budesonide | Budesonide | 20 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 20 | suppressed |
| Nyamyc | Nystatin | 20 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Carvedilol | Carvedilol | 19 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 19 | 15 |
| Promethazine Hcl | Promethazine Hcl | 19 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 18 | 12 |
| Pantoprazole Sodium | Pantoprazole Sodium | 18 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | 12 |
| Testosterone Cypionate | Testosterone Cypionate | 17 | suppressed |
| Aripiprazole | Aripiprazole | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | 11 |
| Famotidine | Famotidine | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Olanzapine | Olanzapine | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 15 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 13 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 13 | suppressed |
| Clinpro 5000 | Fluoride (Sodium) | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Rexulti | Brexpiprazole | 13 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Juluca | Dolutegravir/Rilpivirine | 12 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Nystop | Nystatin | 12 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $189.09 · 1 records | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error